Executive team

Combining a wealth of specialist knowledge and experience, our executive team fosters a culture of collaboration, ambition and innovation, to deliver value for patients, pharma, biotech and healthcare partners our people and investors.

Gordon Cox

Interim Chief Executive Officer

John Gillie

Chief Financial Officer

Jackie Reeves

Human Resources Director

Sir Jonathan Asbridge

Chief Clinical Officer

Dr Sameer Mistry

Chief Medical Officer

Hugues Hervouet

Chief Technology Officer

Geoff Barnett

Managing Director, Chronic Therapies

Mark Hawken

Managing Director, Cancer Services

Julie Gosper

Managing Director, Rare & Specialty